Close X
Tuesday, December 3, 2024
ADVT 
International

Nagara Foundation halts gurdwara renovation work in Pakistan

Darpan News Desk IANS, 20 Jan, 2022 12:05 PM
  • Nagara Foundation halts gurdwara renovation work in Pakistan

New Delhi, Jan 20 (IANS) US-based Ranjit Nagara Foundation, which was overseeing the 'karsewa' (renovation/construction) of Gurdwara Chowa Sahib in Jhelum, Pakistan and other local gurdwaras, has notified that they has stopped the construction activities due to non-compliance of ETPB/PSGPC in providing them bills and expenditure details of the works carried out till date.

Satpreet Singh, Director of Ranjit Nagara Foundation, revealed that as per US rules, their foundation has to provide documentation of their expenditure to Internal Revenue Service, Department of Justice, annually which is further updated on the department's site for public or on before May 15, but the Evacuee Trust Property Board (ETPB) office has not provided the requisite documents till date. Thus, the NGO has to put its activities on hold.

Misappropriation of gurdwara funds by ETPB/PSGPC (Pakistan Sikh Gurdwara Parbandhak Committee) officials had been reported in the past as well.

The Nagara Foundation is largely funded by the Sikh diaspora with resources being further transferred to Pakistan

MORE International ARTICLES

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population
The go-ahead for the vaccine developed by American drugmaker Pfizer and Germany's BioNTech comes as the virus surges again in the United States and Europe, putting pressure on hospitals and morgues in some places and forcing new rounds of restrictions that have devastated economies.

U.K. approves Pfizer coronavirus vaccine for emergency use, this allows England to be one of the 1st countries to begin vaccinating its population

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent
Announcing the results on Monday, Moderna said it has submitted emergency use authorisation from the US Food and Drug Administration (FDA), to apply for a conditional marketing authorisation with the European Medicines Agency (EMA) and to progress with the rolling reviews, which have already been initiated with international regulatory agencies.

Moderna says its vaccine can protect those affected by sever COVID19 cases 100 percent

WATCH: Why are Farmers Up in Arms Against India's Government ?

WATCH: Why are Farmers Up in Arms Against India's Government ?
Protest by thousands of farmers from Punjab and Haryana took place in New Delhi over the weekend entering its fifth day Monday as the farmers continue to showcase their displeasure against the Centre's new farm laws. 

WATCH: Why are Farmers Up in Arms Against India's Government ?

White House still planning holiday parties, despite warnings

White House still planning holiday parties, despite warnings
Monday's delivery of an 18-and-a-half foot tall Fraser fir by horse-drawn carriage signalled the kickoff of the usual array of White House holiday events that will include the annual turkey pardon and Christmas and Hanukkah events.

White House still planning holiday parties, despite warnings

3rd major COVID-19 vaccine shown to be effective and cheaper

3rd major COVID-19 vaccine shown to be effective and cheaper
The results are based on an interim analysis of trials in the U.K. and Brazil of a vaccine developed by Oxford University and manufactured by AstraZeneca.

3rd major COVID-19 vaccine shown to be effective and cheaper

Pfizer seeking emergency use of its COVID-19 vaccine in US

Pfizer seeking emergency use of its COVID-19 vaccine in US
The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.

Pfizer seeking emergency use of its COVID-19 vaccine in US